Hebo Wang

975 total citations
46 papers, 612 citations indexed

About

Hebo Wang is a scholar working on Molecular Biology, Epidemiology and Psychiatry and Mental health. According to data from OpenAlex, Hebo Wang has authored 46 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Epidemiology and 9 papers in Psychiatry and Mental health. Recurrent topics in Hebo Wang's work include MicroRNA in disease regulation (8 papers), Migraine and Headache Studies (7 papers) and Circular RNAs in diseases (7 papers). Hebo Wang is often cited by papers focused on MicroRNA in disease regulation (8 papers), Migraine and Headache Studies (7 papers) and Circular RNAs in diseases (7 papers). Hebo Wang collaborates with scholars based in China, United States and Australia. Hebo Wang's co-authors include Weiliang He, Litao Li, Lipeng Dong, Jingru Zhao, Qianqian Qi, Ming Chang Hu, Jing Xu, Jinming Cheng, Zhijuan Liu and Peiyuan Lv and has published in prestigious journals such as The Science of The Total Environment, Neurology and Scientific Reports.

In The Last Decade

Hebo Wang

40 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hebo Wang China 15 181 167 92 81 73 46 612
Jack Woods Ireland 9 250 1.4× 130 0.8× 136 1.5× 36 0.4× 59 0.8× 18 672
Jane Uyehara‐Lock United States 15 130 0.7× 298 1.8× 188 2.0× 149 1.8× 44 0.6× 21 903
Qingrong Xia China 15 108 0.6× 331 2.0× 159 1.7× 89 1.1× 32 0.4× 55 842
Xiumei Zuo China 12 106 0.6× 131 0.8× 168 1.8× 257 3.2× 45 0.6× 22 683
So Yeon Jeon South Korea 18 113 0.6× 213 1.3× 359 3.9× 262 3.2× 44 0.6× 70 1.0k
Hetao Bian China 14 137 0.8× 175 1.0× 50 0.5× 31 0.4× 165 2.3× 24 666
Sara Nikseresht Iran 13 46 0.3× 136 0.8× 76 0.8× 39 0.5× 59 0.8× 23 469

Countries citing papers authored by Hebo Wang

Since Specialization
Citations

This map shows the geographic impact of Hebo Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hebo Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hebo Wang more than expected).

Fields of papers citing papers by Hebo Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hebo Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hebo Wang. The network helps show where Hebo Wang may publish in the future.

Co-authorship network of co-authors of Hebo Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Hebo Wang. A scholar is included among the top collaborators of Hebo Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hebo Wang. Hebo Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Mingjie, Jin Wu, Hebo Wang, et al.. (2025). Rimegepant for the acute treatment of migraine: A phase 3, multicenter, open-label, long-term safety and effectiveness study in adults from China. Cephalalgia. 45(10). 2235416742–2235416742. 1 indexed citations
2.
Zhang, Yang, et al.. (2025). ZNF655-mediated neuroprotection in cerebral ischemia-reperfusion injury via Akt/Nrf2 pathway modulation. Brain Research. 1872. 150091–150091.
3.
Wang, Hebo, et al.. (2025). Intracranial infection in an adult caused by Mycoplasma hominis, diagnosed using mNGS technology: a case report. Frontiers in Medicine. 12. 1560635–1560635. 1 indexed citations
4.
5.
Feng, Ge, et al.. (2025). The relevance of resveratrol in ameliorating carotid atherosclerosis through glycolysis. BMC Cardiovascular Disorders. 25(1). 301–301.
6.
7.
8.
Zhang, Kuo, et al.. (2024). Primary intracranial malignant melanoma in an adolescent girl with NRAS and TP53 mutations: case report and literature review. Frontiers in Oncology. 14. 1465676–1465676. 1 indexed citations
9.
Zhang, Kaihua, et al.. (2023). Serum uric acid predicts the development of atherosclerosis in women but not in men: A ten-year cohort study in China. Nutrition Metabolism and Cardiovascular Diseases. 34(1). 198–205. 1 indexed citations
10.
Yu, Shengyuan, Byung‐Kun Kim, Hebo Wang, et al.. (2022). A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study. The Journal of Headache and Pain. 23(1). 146–146. 12 indexed citations
11.
12.
Li, Litao, et al.. (2022). Integrated Analysis of Competitive Endogenous RNA Networks in Acute Ischemic Stroke. Frontiers in Genetics. 13. 833545–833545. 11 indexed citations
13.
Zhao, Jingru, Lipeng Dong, Jinming Cheng, et al.. (2021). O-GlcNAc Transferase (OGT) Protects Cerebral Neurons from Death During Ischemia/Reperfusion (I/R) Injury by Modulating Drp1 in Mice. NeuroMolecular Medicine. 24(3). 299–310. 19 indexed citations
14.
Zhang, Kaihua, Weiliang He, Gongbo Chen, et al.. (2020). The association between ambient air pollution and blood lipids: A longitudinal study in Shijiazhuang, China. The Science of The Total Environment. 752. 141648–141648. 52 indexed citations
15.
Li, Litao, Lipeng Dong, Zhen Xiao, et al.. (2020). Integrated analysis of the proteome and transcriptome in a MCAO mouse model revealed the molecular landscape during stroke progression. Journal of Advanced Research. 24. 13–27. 36 indexed citations
16.
Li, Litao, Lipeng Dong, Jingru Zhao, et al.. (2020). Circulating miRNA‐3552 as a Potential Biomarker for Ischemic Stroke in Rats. BioMed Research International. 2020(1). 4501393–4501393. 11 indexed citations
17.
Yu, Shengyuan, Ye Ran, Qi Wan, et al.. (2019). Efficacy and Safety of Toutongning Capsule in Patients with Migraine: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. The Journal of Alternative and Complementary Medicine. 25(12). 1215–1224. 8 indexed citations
18.
He, Weiliang, et al.. (2019). Role of liraglutide in brain repair promotion through Sirt1‐mediated mitochondrial improvement in stroke. Journal of Cellular Physiology. 235(3). 2986–3001. 35 indexed citations
19.
Hu, Ming Chang, Zhijuan Liu, Peiyuan Lv, et al.. (2016). Autophagy and Akt/CREB signalling play an important role in the neuroprotective effect of nimodipine in a rat model of vascular dementia. Behavioural Brain Research. 325(Pt A). 79–86. 54 indexed citations
20.
Wang, Jianhua, Peiyuan Lv, Hebo Wang, et al.. (2013). Diffusion tensor imaging measures of normal appearing white matter in patients who are aging, or have amnestic mild cognitive impairment, or Alzheimer’s disease. Journal of Clinical Neuroscience. 20(8). 1089–1094. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jack Woods Breakdown of academic impact, for papers by Jane Uyehara‐Lock Breakdown of academic impact, for papers by Qingrong Xia Breakdown of academic impact, for papers by Xiumei Zuo Breakdown of academic impact, for papers by So Yeon Jeon Breakdown of academic impact, for papers by Hetao Bian Breakdown of academic impact, for papers by Sara Nikseresht
Rankless by CCL
2026